Filed Pursuant to Rule 424(b)(2)
Registration No. 333-287303
Pricing Supplement to the Prospectus dated May 15, 2025, to the Prospectus Supplement dated May 15, 2025 and to the Underlying Supplement dated May 15, 2025.
Barclays Bank PLC $6,583,000 Digital S&P 500® Index-Linked Global Medium-Term Notes, Series A, due 2027
The notes will not bear interest. The amount that you will be paid on your notes on the stated maturity date (November 10, 2027) is... (continue reading...)
As filed with the Securities and Exchange Commission on October 13, 2026
1933 Act Registration No. 333-200933
1940 Act Registration No. 811-23013
United States
Securities and Exchange Commission
Washington, D.C. 20549
Form N-1A
Registration Statement
UNDER
THE SECURITIES ACT OF 1933 ☒ Pre-Effective Amendment No. ___ ☐ Post-Effective Amendment No. 730 ☒and/or
REGISTRATION STATEMENT
UNDER
... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D Safe Water Devices, LLC
-
Form D Gulf & Shield Resources
-
Form D LEVEL ONE LABS, Inc.
-
Form 424B2 BARCLAYS BANK PLC
-
Form FWP BofA Finance LLC Filed by: BofA Finance LLC
-
Form 497 EAIC VARIABLE CONTRACT
-
Form 13F-HR Windsor Capital Manageme For: Sep 30
-
Form SCHEDULE 13G FRACTYL HEALTH, INC. Filed by: Catalio Capital Management, LP
-
Form 13F-HR Fiduciary Alliance LLC For: Sep 30
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form N-CEN FIRST TRUST EXCHANGE-TRA For: Jul 31
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 497 EAIC VARIABLE CONTRACT
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form D/A Artia Global Alpha Fund
-
Form 13F-HR Boston Common Asset Mana For: Sep 30
-
Form SCHEDULE 13G HUBSPOT INC Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A KULICKE & SOFFA INDUSTRI Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A ENTERGY CORP /DE/ Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
-
Form 13F-HR Founders Capital Managem For: Sep 30
-
Form N-CEN FIRST TRUST EXCHANGE-TRA For: Jul 31
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form D FSX Retail 37, DST
-
Form D SOAR.COM, INC.
-
Form 497 REX ETF Trust
-
Form D/A Venture Growth Select
-
Form N-CEN FIRST TRUST EXCHANGE-TRA For: Jul 31
-
Form 3 BOSTON BEER CO INC For: Oct 12 Filed by: Stranksy Allison Robl
-
Form D ATJustice, PBC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 MORGAN STANLEY
-
Form D/A Fossil Creek Minerals
-
Form 13F-HR WT Wealth Management For: Sep 30
-
Form D Lumyna Alternative Funds
-
Form 4 LATTICE SEMICONDUCTOR For: Oct 10 Filed by: Tamer Ford
-
Form SC TO-I/A ABS Long/Short Strategie Filed by: ABS Long/Short Strategies Fund
-
Form SCHEDULE 13G RHYTHM PHARMACEUTICALS, Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G H World Group Ltd Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G REGENXBIO Inc. Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G Veradermics, Inc Filed by: JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A MIDDLEBY Corp Filed by: JPMORGAN CHASE & CO
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 13F-HR Aaron Wealth Advisors For: Sep 30
-
Form 13F-HR Legal Advantage Investme For: Sep 30
-
Form D Encapitalist Holdings
-
Form 144 BLUE BIOFUELS, INC. Filed by: Kneppers Chris J


